{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:19:46Z","timestamp":1778584786750,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004807","name":"California Department of Fish and Game","doi-asserted-by":"publisher","award":["MU 4812\/2-1:2"],"award-info":[{"award-number":["MU 4812\/2-1:2"]}],"id":[{"id":"10.13039\/100004807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["498537330"],"award-info":[{"award-number":["498537330"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijgc.2024.100010","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T03:59:24Z","timestamp":1735617564000},"page":"100010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility and safety of hyperthermic intra-peritoneal chemotherapy in patients with ovarian cancer and chronic kidney disease"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-5073","authenticated-orcid":false,"given":"Carolin","family":"Mueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-5012","authenticated-orcid":false,"given":"Gabriella","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-6830","authenticated-orcid":false,"given":"Meng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-7817","authenticated-orcid":false,"given":"Johanna","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"DeBernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2024.100010_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijgc.2024.100010_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Armstrong","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100010_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ijgc.2024.100010_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100010_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the multicenter intergroup study DESKTOP II. A project of the AGO Kommission OVAR, AGO study group, NOGGO, AGO-Austria, and MITO","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"23","key":"10.1016\/j.ijgc.2024.100010_bib6","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100010_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(17)30279-6","article-title":"Bevacizumab and paclitaxel\u2013carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology\/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Coleman","year":"2017","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2024.100010_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","article-title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2024.100010_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100010_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/jso.23688","article-title":"Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer improves progression-free survival, especially in BRCA-positive patients-a case-control study","volume":"110","author":"Safra","year":"2014","journal-title":"J Surg Oncol"},{"issue":"23","key":"10.1016\/j.ijgc.2024.100010_bib11","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.21.00605","article-title":"Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: an MSK team ovary phase II study","volume":"39","author":"Zivanovic","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100010_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2022.10.010","article-title":"Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: a meta-analysis","volume":"167","author":"Kim","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100010_bib13","article-title":"Past, present, and future of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer","volume":"13","author":"Mishra","year":"2021","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100010_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ygyno.2020.06.487","article-title":"A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology","volume":"158","author":"Chambers","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2024.100010_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"BioMed Res Int"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100010_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.ijgc.2024.100010_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.804685","article-title":"Protective effect of mannitol on cisplatin-induced nephrotoxicity: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100010_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1078155216656927","article-title":"Mannitol for the prevention of cisplatin-induced nephrotoxicity: a retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center","volume":"23","author":"Williams","year":"2017","journal-title":"J Oncol Pharm Pract"},{"issue":"13","key":"10.1016\/j.ijgc.2024.100010_bib19","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1245\/s10434-023-14216-6","article-title":"Impact of sodium thiosulfate on prevention of nephrotoxicities in HIPEC: an ancillary evaluation of cisplatin-induced toxicities in ovarian cancer","volume":"30","author":"Senguttuvan","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.107955","article-title":"Eliminating the need for pre-operative intravenous hyperhydration: sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients \u2013 a retrospective analysis","volume":"50","author":"Vachez","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100010_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0301-2115(02)00234-8","article-title":"Renal impairment in patients with ovarian cancer","volume":"106","author":"Donadio","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.ijgc.2024.100010_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13940","article-title":"Evaluation of cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for stage III epithelial ovarian cancer","volume":"3","author":"Lei","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100010_bib23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijgc.2024.100010_bib24","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"issue":"9","key":"10.1016\/j.ijgc.2024.100010_bib25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","article-title":"NCCN guidelines\u00ae insights: ovarian cancer, version 3.2022","volume":"20","author":"Armstrong","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"suppl 24","key":"10.1016\/j.ijgc.2024.100010_bib26","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1002\/cncr.32505","article-title":"Hyperthermic intraperitoneal chemotherapy for ovarian cancer: the heat is on","volume":"125","author":"Koole","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100010_bib27","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2019-0029","article-title":"Survey on the current gynaecological approach of ovarian cancer patients: the utility of HIPEC","volume":"5","author":"Iavazzo","year":"2020","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100010_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.14336\/AD.2020.0703","article-title":"Aging and renal disease: old questions for new challenges","volume":"12","author":"Chou","year":"2021","journal-title":"Aging Dis"},{"issue":"7","key":"10.1016\/j.ijgc.2024.100010_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/ijgc-2021-002622","article-title":"Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry","volume":"31","author":"Chambers","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100010_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.ijgc.2024.100010_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1094410","article-title":"Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer","volume":"13","author":"Bai","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100010_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.14740\/wjon1540","article-title":"Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a Portuguese population","volume":"13","author":"Carias","year":"2022","journal-title":"World J Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100010_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1245\/s10434-021-10376-5","article-title":"HIPEC-induced acute kidney injury: a retrospective clinical study and preclinical model","volume":"29","author":"Liesenfeld","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100010_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ijgc-2018-000099","article-title":"Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis","volume":"29","author":"Angeles","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100010_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2024.2304250","article-title":"Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy","volume":"41","author":"Cheng","year":"2024","journal-title":"Int J Hyperthermia"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100010_bib36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/02656736.2017.1293304","article-title":"Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"33","author":"Sin","year":"2017","journal-title":"Int J Hyperthermia"},{"issue":"13","key":"10.1016\/j.ijgc.2024.100010_bib37","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1245\/s10434-012-2496-y","article-title":"Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience","volume":"19","author":"Bell","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100010_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","article-title":"Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial","volume":"157","author":"Lim","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ijgc.2024.100010_bib39","article-title":"Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer","volume":"40","author":"Chambers","year":"2022","journal-title":"Gynecol Oncol Rep"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24003669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24003669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:03:14Z","timestamp":1778583794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1048891X24003669"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2024.100010","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and safety of hyperthermic intra-peritoneal chemotherapy in patients with ovarian cancer and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2024.100010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100010"}}